Open AccessThe use of combination of fibrinolytic therapy and abciximab in the treatment of the acute myocardial infarction with ST elevation
Author(s) -
Branko Gligić,
Dragan Dinčić,
Slobodan Obradović,
Milić Marković,
Vjekoslav Orozović
Publication year - 2002
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp0206675g
Subject(s) - abciximab , medicine , myocardial infarction , cardiology , acute coronary syndrome , st elevation , reperfusion therapy , coronary care unit , chest pain , streptokinase , st segment , partial thromboplastin time , platelet , percutaneous coronary intervention
According to current knowledge, the best way to treat the acute myocardial infarction with ST elevation is primary transluminal coronary angioplasty, which can be performed only in the best equipped tertiary cardiology centers. As it was known that atherothrombosis wais the essence of the acute coronary syndrome we wanted to examine the efficacy and safety of combined therapy of tissue plasminogen activator and glycoprotein IIbIIIa platelet receptor antagonist abciximab.